In the Philippines, diabetes is rapidly becoming a major public health issue, as in other low- and middle-income countries. Availability and affordability of care and medicines are crucial to control diabetes. This study describes the situations of diabetes patients and identifies possible barriers to diabetes care and medicines in the Philippines. Quantitative and qualitative data were collected from multilevel respondents using different semistructured questionnaires/checklists. The study revealed that many patients took intermittent medication based on their own judgment, and/or selected certain pieces of medical advice, subjectively weighing symptoms against household budget. The current public health insurance scheme and decentralized ...
To determine and quantify the prevalence of patient, provider and system level barriers to achieving...
BACKGROUND: Patients with type 2 diabetes often require insulin as the disease progresses. However, ...
This study aimed to describe cost of illness in type 2 diabetes mellitus patients with two oral ant...
Diabetes is a non-communicable disease which accounts for the fifth among the top causes of mortalit...
Background: Diabetes is increasing at an alarming rate in Asian countries including the Philippines....
Diabetes is an emerging health threat in Bangladesh. The study objectives were to evaluate self-mana...
The purpose of this study is to explore the barriers that have an impact on the adherence to therape...
Among immigrants in the United States, Filipinos are the fourth largest group by country of origin w...
International audienceAIM: To assess the effectiveness of the Diabetes Project in Davao City, Philip...
This review will highlight the current challenges and barriers to diabetes management in low and low...
Aims: To improve access and quality of diabetes care for people in low-income countries, it is impor...
AbstractAimsTo improve access and quality of diabetes care for people in low-income countries, it is...
Introduction: Noncommunicable diseases (NCDs) significantly contribute to morbidity and mortality wo...
Background: In 2016, an estimated 872,000 Kenyans were living with diabetes, a country average of 4%...
As the Philippines adopts major reforms under the Universal Health Care Act and embarks on an integr...
To determine and quantify the prevalence of patient, provider and system level barriers to achieving...
BACKGROUND: Patients with type 2 diabetes often require insulin as the disease progresses. However, ...
This study aimed to describe cost of illness in type 2 diabetes mellitus patients with two oral ant...
Diabetes is a non-communicable disease which accounts for the fifth among the top causes of mortalit...
Background: Diabetes is increasing at an alarming rate in Asian countries including the Philippines....
Diabetes is an emerging health threat in Bangladesh. The study objectives were to evaluate self-mana...
The purpose of this study is to explore the barriers that have an impact on the adherence to therape...
Among immigrants in the United States, Filipinos are the fourth largest group by country of origin w...
International audienceAIM: To assess the effectiveness of the Diabetes Project in Davao City, Philip...
This review will highlight the current challenges and barriers to diabetes management in low and low...
Aims: To improve access and quality of diabetes care for people in low-income countries, it is impor...
AbstractAimsTo improve access and quality of diabetes care for people in low-income countries, it is...
Introduction: Noncommunicable diseases (NCDs) significantly contribute to morbidity and mortality wo...
Background: In 2016, an estimated 872,000 Kenyans were living with diabetes, a country average of 4%...
As the Philippines adopts major reforms under the Universal Health Care Act and embarks on an integr...
To determine and quantify the prevalence of patient, provider and system level barriers to achieving...
BACKGROUND: Patients with type 2 diabetes often require insulin as the disease progresses. However, ...
This study aimed to describe cost of illness in type 2 diabetes mellitus patients with two oral ant...